Q4 2012
Released Feb 26, 2013, during market hours
10-K filed Feb 26, 2013, 57 days after period end · 0001477932-13-000891
Q4 2012 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$5.02M$5.02M derivedN/M vs Q4 2011N/M vs Q3 2012
EPS, diluted—Not derived. Share counts vary by quarter.
Free Cash Flowderived-$1,039,434—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2012dderived from reported figures | Q4 2011 |
|---|---|---|
| Net Income | $5.02M | -$5.16K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR